On May 1, the U.S. Food and Drug Administration (FDA) approved Elelyso (taliglucerase alfa) for the treatment of Gaucher disease. Read more.

FDA approves Elelyso for Gaucher disease

New abdominal surgical set clears FDA

FDA approves Votrient for advanced soft tissue sarcoma

FDA approves new imaging agent to help identify AD

FDA warns of danger of ‘Japan Rapid Weight Loss Diet Pills Yellow’

Quiz Time

Standardized patient “hand off” reduces medical errors

200 years of surgery reviewed

Study: Men more likely than women to return to hospital within 30 days of discharge

Study: Patients commonly misuse medications

More Baby Boomers facing old age alone

The Atlantic publishes article on nurse leadership in ACOs

Injury patterns in competitive college athletes identified

Pelvic floor muscle exercises effective for urinary incontinence in women

When caregiving ignites burnout – New ways to douse the flames

Emotional intelligence: Why walking the talk transforms nursing care

Genetic counseling, abortion, sex-selection, and autonomy—a response to readers’ comments

The fall-response team: An innovative approach

From our readers…Are you prepared for a mass casualty event?

How to prevent falls among older adults in outpatient settings

Does periodontal disease contribute to preterm birth?

Putting evidence into practice: Pain

ANA ‘joins forces’ with first lady to help veterans

Unite to Fight the Flu – Influenza Season Update

Clinical trials 101

Myasthenia gravis: An update

Psychiatric emergencies in med-surg patients: Are you prepared?

American Nurse Today Wins Two ASHPE Award

Wound Healing Improves With New Bioactive Peptide Combo

Nurse leaders, Dr. Jill Biden, and First Lady Michelle Obama join forces to announce new initiative to help veterans and their families

Our Readers Respond

Letter to the Editor

Precision and perfection

Quick-reference I.V. tools reduce stress in ICU nurses

Accountability: A concept worth revisiting

FDA releases draft guidance documents on tobacco